Cargando…

Rational drug design of CB2 receptor ligands: from 2012 to 2021

Cannabinoid receptors belong to the large family of G-protein-coupled receptors, which can be divided into two receptor types, cannabinoid receptor type-1 (CB1) and cannabinoid receptor type-2 (CB2). Marinol, Cesamet and Sativex are marketed CB1 drugs which are still in use and work well, but the ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Yan-ran, Tang, Jia-qin, Zhang, Wan-nian, Zhuang, Chun-lin, Shi, Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Royal Society of Chemistry 2022
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730932/ https://www.ncbi.nlm.nih.gov/pubmed/36540233 http://dx.doi.org/10.1039/d2ra05661e

Ejemplares similares

Design, synthesis and biological evaluation of novel orthosteric-allosteric ligands of the cannabinoid receptor type 2 (CB(2)R)
por: Ferrisi, Rebecca, et al.
Publicado: (2022)

Rational Design, Synthesis, and Evaluation of Fluorescent CB(2) Receptor Ligands for Live-Cell Imaging: A Comprehensive Review
por: Bhattacharjee, Pinaki, et al.
Publicado: (2023)

Rationally Designed DNA Nanostructures for Drug Delivery
por: Xu, Fan, et al.
Publicado: (2020)

Enhancing H(2) evolution performance of an immobilised cobalt catalyst by rational ligand design
por: Willkomm, Janina, et al.
Publicado: (2015)

Rational design of yolk–shell nanostructures for drug delivery
por: Mohammadi Ziarani, Ghodsi, et al.
Publicado: (2020)

Facing Diseases Caused by Trypanosomatid Parasites: Rational Design of Pd and Pt Complexes With Bioactive Ligands
por: Gambino, Dinorah, et al.
Publicado: (2022)

Editorial: Rational drug design of metal complexes for cancer therapy
por: Morais, Tânia S., et al.
Publicado: (2022)

Ligand discrimination during virtual screening of the CB1 cannabinoid receptor crystal structures following cross-docking and microsecond molecular dynamics simulations
por: Loo, Jason S. E., et al.
Publicado: (2019)

Probing biotin receptors in cancer cells with rationally designed fluorogenic squaraine dimers
por: Fam, Kyong T., et al.
Publicado: (2020)

Structural insights into targeting of the colchicine binding site by ELR510444 and parbendazole to achieve rational drug design
por: Lei, Jia-Hong, et al.
Publicado: (2021)

Rational design of an “all-in-one” phototheranostic
por: Yang, Zi-Shu, et al.
Publicado: (2020)

Precise immunological evaluation rationalizes the design of a self-adjuvanting vaccine composed of glycan antigen, TLR1/2 ligand, and T-helper cell epitope
por: Chang, Tsung-Che, et al.
Publicado: (2022)

Rational Design of Antiangiogenic Helical Oligopeptides Targeting the Vascular Endothelial Growth Factor Receptors
por: Zanella, Simone, et al.
Publicado: (2019)

The role of CB(2) receptor ligands in human eosinophil function
por: Frei, Robert, et al.
Publicado: (2012)

Discovery of Homobivalent Bitopic Ligands of the Cannabinoid CB(2) Receptor
por: Morales, Paula, et al.
Publicado: (2020)

Structure-guided design of CPPC-paired disulfide-rich peptide libraries for ligand and drug discovery
por: Wu, Yapei, et al.
Publicado: (2022)

Design, Synthesis, and Biological Activity of New CB2 Receptor Ligands: from Orthosteric and Allosteric Modulators to Dualsteric/Bitopic Ligands
por: Gado, Francesca, et al.
Publicado: (2022)

Editorial: Rational Design of Multi-Functional Nanomaterials
por: Lodeiro, Carlos, et al.
Publicado: (2019)

Rational Design of Smart Hydrogels for Biomedical Applications
por: Zhang, Yanyu, et al.
Publicado: (2021)

Rational Design and Biological Application of Antioxidant Nanozymes
por: Tian, Ruizhen, et al.
Publicado: (2021)

Rational design of bifunctional conjugated microporous polymers
por: Song, Yanpei, et al.
Publicado: (2021)

Editorial: Rational design and preparation of nanostructured biomaterials
por: Li, Jianhua, et al.
Publicado: (2022)

Rational design of adhesives for effective underwater bonding
por: Li, Sidi, et al.
Publicado: (2022)

Reviewing Ligand-Based Rational Drug Design: The Search for an ATP Synthase Inhibitor
por: Lee, Chia-Hsien, et al.
Publicado: (2011)

A Mathematical Model for the Rational Design of Chimeric Ligands in Selective Drug Therapies
por: Doldán-Martelli, V, et al.
Publicado: (2013)

Imposing control on self-assembly: rational design and synthesis of a mixed-metal, mixed-ligand coordination cage containing four types of component
por: Metherell, Alexander J., et al.
Publicado: (2016)

Candidate Therapeutics by Screening for Multitargeting Ligands: Combining the CB2 Receptor With CB1, PPARγ and 5-HT4 Receptors
por: El-Atawneh, Shayma, et al.
Publicado: (2022)

Rational Drug Design of Axl Tyrosine Kinase Type I Inhibitors as Promising Candidates Against Cancer
por: Sarukhanyan, Edita, et al.
Publicado: (2020)

Rational design of sequestered DNAzyme beacons to enable flexible control of catalytic activities
por: Tang, Wei, et al.
Publicado: (2018)

Expression and Function of Cannabinoid Receptors CB1 and CB2 and Their Cognate Cannabinoid Ligands in Murine Embryonic Stem Cells
por: Jiang, Shuxian, et al.
Publicado: (2007)

Achieving nano-gold stability through rational design
por: Barrett, Dean H., et al.
Publicado: (2016)

Editorial: Nanozymes: From Rational Design to Biomedical Applications
por: Fan, Kelong, et al.
Publicado: (2021)

Rational designing of glyco-nanovehicles to target cellular heterogeneity
por: Jain, Prashant, et al.
Publicado: (2021)

Rational design and topochemical synthesis of polymorphs of a polymer
por: Athiyarath, Vignesh, et al.
Publicado: (2023)

Alchemical absolute protein–ligand binding free energies for drug design
por: Khalak, Y., et al.
Publicado: (2021)

Rational drug design
por: Truhlar, Donald, et al.
Publicado: (1999)

Rational design of red AIEgens with a new core structure from non-emissive heteroaromatics
por: Chen, Ming, et al.
Publicado: (2018)

Rationally designed structure of mesoporous carbon hollow microspheres to acquire excellent microwave absorption performance
por: Qin, Yuxuan, et al.
Publicado: (2021)

Covalent inhibitors: a rational approach to drug discovery
por: Sutanto, Fandi, et al.
Publicado: (2020)

Exploring G Protein-Coupled Receptors (GPCRs) Ligand Space via Cheminformatics Approaches: Impact on Rational Drug Design
por: Basith, Shaherin, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_lb1upens8rgd0sfa7f9htphmn2